Dr. Vanessa Zann is an Executive Drug Development Consultant at Quotient Sciences, with over twenty-five years industry experience providing expert biopharmaceutic support to drug discovery, early drug development and clinical program design.

Vanessa holds a PhD in Pharmaceutical Science, and completed postdoctoral research in buccal transport, before joining AstraZeneca as a permeability expert in the Pharmaceutical Development department,  leading the global Caco-2 facility and selection of new chemical entities with appropriate biopharmaceutical properties.  

Since joining Quotient Sciences in 2012, Vanessa has provided study design and scientific leadership to over 100 clinical pharmacology and drug product optimization studies across a wide range of applications including first-in-human, drug-drug interaction and development and optimization of solubility enhanced and modified release formulations. She led the implementation of modelling and simulation services and application of in-vitro characterization strategies to Quotients development programs.